Cargando…

Probing the therapeutic potential of TRPC6 for Alzheimer’s disease in live neurons from patient-specific iPSCs

The induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to model and study Alzheimer’s disease (AD) under patient-specific genetic background. The lower expression of transient receptor potential canonical 6 (TRPC6) was associated with AD patients, which might be involved in AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Ran, Lu, Rui, Wang, Junfeng, Zeng, Shujun, Zhang, Ting, Guo, Wenke, Zhang, Xiaobing, Cheng, Qi, Yue, Chunmei, Wang, Yizheng, Jing, Naihe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816687/ https://www.ncbi.nlm.nih.gov/pubmed/32492143 http://dx.doi.org/10.1093/jmcb/mjaa027

Ejemplares similares

TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production
por: Wang, Junfeng, et al.
Publicado: (2015)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease
por: Cavalli, Eugenio, et al.
Publicado: (2020)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
por: Burke, Emily E., et al.
Publicado: (2020)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons
por: Castillo Bautista, Cristina Marisol, et al.
Publicado: (2023)

Caveolin-1 Phosphorylation Is Essential for Axonal Growth of Human Neurons Derived From iPSCs
por: Wang, Shanshan, et al.
Publicado: (2019)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Neuronal Cell Sheets of Cortical Motor Neuron Phenotype Derived from Human iPSCs
por: Suzuki, Noboru, et al.
Publicado: (2017)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Early pathogenic event of Alzheimer’s disease documented in iPSCs from patients with PSEN1 mutations
por: Yang, Juan, et al.
Publicado: (2016)

Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons
por: Huo, Hai-Qin, et al.
Publicado: (2018)

Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs
por: Yokota, Mutsumi, et al.
Publicado: (2017)

Improved and Flexible HDR Editing by Targeting Introns in iPSCs
por: Fu, Juan, et al.
Publicado: (2022)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
por: Jiang, Aiwen, et al.
Publicado: (2022)

Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
por: Shum, Carole, et al.
Publicado: (2015)

The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs
por: Palombo, Flavia, et al.
Publicado: (2021)

Human Neural Stem Cells Reinforce Hippocampal Synaptic Network and Rescue Cognitive Deficits in a Mouse Model of Alzheimer's Disease
por: Zhang, Ting, et al.
Publicado: (2019)

In vivo reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury
por: Gao, Xiang, et al.
Publicado: (2016)

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
por: Marei, Hany E., et al.
Publicado: (2023)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5k8s3to8m61n3hf26vk5kjcvn